ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 50

Intra-Articularly Delivering Lentivirus-Based CRISPR Interference Targeting Long Non-Coding RNA H19 in Synovial Fibroblasts Ameliorates Experimental Arthritis

Chrong-Reen Wang1, Shih-Yao Chen2, Yu-Ting Lo3, Yu-Chi Chou4, Ming-Fei Liu1, Chao-Liang Wu5 and Ai-Li Shiau3, 1Internal Medicine, National Cheng Kung University Hospital and Medical College, Tainan, Taiwan, 2Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, 3Microbiology and Immunology, National Cheng Kung University Medical College, Tainan, Taiwan, 4Core Facility for Manipulation of Gene Function, Academia Sinica, Taipei, Taiwan, 5Biochemistry and Molecular Biology, National Cheng Kung University Medical College, Tainan, Taiwan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Fibroblasts, pathogenesis and rheumatoid arthritis, rheumatoid arthritis, treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Aberrantly higher expression of long non-coding RNAs (lncRNAs) in synovial fibroblasts (SFs) plays pathogenic roles in rheumatoid joint. Studying the effects on knocking down lncRNAs expression in arthritis models would contribute to the development of lncRNAs-related therapeutics in rheumatoid arthritis (RA). We examined whether intra-articularly (i.a.) delivering the lentivirus (LV)-based CRISPR interference (CRISPRi) targeting H19, an oncofetal lncRNA involved in tumor metastasis, in SFs can ameliorate experimental arthritis.

Methods: H19 expression levels were examined by quantitative real-time PCR (qRT-PCR) in mononuclear cells (MNCs) from RA before and after receiving a TNF blockade therapy and osteoarthritis (OA) patients. Synovial tissues were from arthritis patients and an experimental model, collagen-induced arthritis (CIA). SFs were purified from patients, and normal human SFs were obtained commercially. Single guide RNA oligonucleotides that directing Cas9 to target sites were designed according to available algorisms. A 1.9 kb stuffer was removed from LV plasmid pAll-dCAS9-KRAB.pPuro for cloning, and created single guide RNA vectors were transiently transfected into 293T cells to obtain recombinant LV vectors. SFs were transduced with LVCRISPRi-H19 under polybrene, followed by selection with puromycin incubation to produce stable H19-silenced transfectants. Cell lysates were subjected to immunoblot with anti-EZH2, anti-pGSK-3β (a Wnt signaling) and anti-Snail. Cell invasion was assayed by Transwells with membrane coated with Matrigel. Spernatant IL-6 was quantified by ELISA. Arthritis indexes and histological scores were evaluated in CIA joints receiving LVCRISPRi-H19 or LVCRISPRi-GFP (negative control) injection, and synovial H19 expression was examined by qRT-PCR.

Results: Synovial tissues, SFs and MNCs from RA had higher H19 expression as compared with OA patients. RA MNCs had lower H19 expression after a TNF blockade injection. H19 and EZH2 levels were up-regulated in normal SFs in the presence of TNF in vitro. Lower EZH2, pGSK-3β and Snail expression was found in H19-silenced SF transfectants. LVCRISPRi-H19-injected CIA joints with lower synovial H19 expression had reduced arthritis indexes and histological scores.

Conclusion: Our results demonstrate that a TNF-mediated lncRNA pathway with H19-EZH2-Wnt signaling-Snail axis might exist in RASFs, and i.a. delivering CRISPRi targeting lncRNA H19 in SFs could ameliorates experimental arthritis.


Disclosure: C. R. Wang, None; S. Y. Chen, None; Y. T. Lo, None; Y. C. Chou, None; M. F. Liu, None; C. L. Wu, None; A. L. Shiau, None.

To cite this abstract in AMA style:

Wang CR, Chen SY, Lo YT, Chou YC, Liu MF, Wu CL, Shiau AL. Intra-Articularly Delivering Lentivirus-Based CRISPR Interference Targeting Long Non-Coding RNA H19 in Synovial Fibroblasts Ameliorates Experimental Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/intra-articularly-delivering-lentivirus-based-crispr-interference-targeting-long-non-coding-rna-h19-in-synovial-fibroblasts-ameliorates-experimental-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intra-articularly-delivering-lentivirus-based-crispr-interference-targeting-long-non-coding-rna-h19-in-synovial-fibroblasts-ameliorates-experimental-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology